Peptide vaccines for hepatocellular carcinoma

Immunotherapy is a potentially attractive treatment option for patients with hepatocellular carcinoma (HCC). We have reported that glypican-3 (GPC3) is an ideal target for anticancer immunotherapy against HCC because its expression is specifically detected in > 80% of HCCs, even during the early...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Nobuoka, Daisuke, Yoshikawa, Toshiaki, Sawada, Yu, Fujiwara, Toshiyoshi, Nakatsura, Tetsuya
Médium: Artigo
Jazyk:Inglês
Vydáno: Landes Bioscience 2013
Témata:
Commentary
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3667940/
https://ncbi.nlm.nih.gov/pubmed/23442593
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/hv.22473
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky